11 May 2022 Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer Press Releases SAN…
2 May 2022 Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) Press Releases
2 May 2022 Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD) Press Releases CAMBRIDGE, Mass.–(
2 May 2022 Forge Biologics Announces 7 Presentations at the Upcoming Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Press Releases
2 May 2022 DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors Press Releases SAN DIEGO–(
2 May 2022 Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of Directors Press Releases PASADENA, Calif.–(
2 May 2022 Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma Press Releases NEW YORK & LONDON…
2 May 2022 Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer Press Releases WALTHAM,…
2 May 2022 VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine Press Releases
2 May 2022 Affinivax to Highlight Preclinical Data from COVID-19 MAPS™ Vaccine Development Program at IMMUNOLOGY2022™ Press Releases CAMBRIDGE, Mass.–(…
